ReviewCancers2023

Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer.

Yi Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.